Chun Wo Charitable Foundation Limited (“Chun Wo Charitable Foundation” or “Chun Wo”) has sought to help the underprivileged in the community in the wake of coronavirus outbreak. It has donated more than 200,000 surgical masks to people in need through various social welfare agencies and children hospitals. Chun Wo has also distributed a portion of the surgical masks to frontline construction workers through subcontractors in the industry and via Construction Industry Council, so as to help address their immediate needs. In addition, Chun Wo Charitable Fund will donate HK$400,000 in total to support efforts from various fields to battle the…
Author: Marie Jones
Read More
NetDragon Websoft Holdings Limited (“NetDragon” or “the Company”, Hong Kong Stock Code: 777), a global leader in building internet communities, is pleased to announce that the Company has entered into a strategic agreement with RYB Education, Inc (“RYB Education”), joining forces to explore online early childhood education in China. This collaboration broadens NetDragon’s online education product offerings and services in early childhood education and at-home education, as well as opening up such markets in China. Leveraging the achievements and advantages of NetDragon’s education technologies and products, while integrating with the platform resources from RYB Education, this strategic cooperation aims to…
1. Targeted by a short seller, China Medical System fought back with a strong response and large-scale buyback In recent years it has been common for short sellers who are active in the Hong Kong stock market to target “high-performing stocks”. However, most of these actions have been in vain, the targeted companies with solid fundamentals have withstood these tests and their stock prices performed well again in the secondary market, fighting back against the short sellers. Recently, the short-seller Blue Orca issued a short selling report of China Medical System, a…
Holista CollTech (ASX:HCT) (“Holista”) announced today it will co-develop and produce in Malaysia the world’s first nasal sanitising balm using Path-Away(R), a plant-based alcohol-free active ingredient that has proven successful in killing all previously tested corona type viruses without harming humans. Path-Away(R), which has been tested and proven to kill more than 170 pathogens (including viruses, bacteria, and fungi), was developed by Global Infection Control Consultants LLC (“GICC LCC”). It kills the AIDS virus and the resilient Mycobacterium tuberculosis. In Malaysia, it is approved by the Ministry of Health as being effective against the H1N1 virus. GICC LLC, based in…
Aims for development of next-generation IoT products Maker Village, joint initiative of the Ministry of Electronics and Information Technology (MeitY), Government of India and IIITM, Kerala Cavli Wireless, a global leader in cellular Internet of Things (IoT) solutions, and Maker Village, the Indian IoT and hardware innovation hub, are collaborating to launch India’s first 5G network test lab in Q3 2020. The lab will enable IoT OEMs and ODMs to test their prototypes in real-world settings to fast track the product development processes, and will mark the first time Indian engineering teams have access to a local cutting-edge, fully functional…
Holista將含Path-Away(R)成分的消毒液的分銷範圍擴展至東盟，英國和歐洲 Holista CollTech（ASX代碼：HCT）（以下簡稱“Holista”或本公司）今日宣布，它將在馬來西亞與合作夥伴一起共同研發和生產世界上第一款使用Path-Away®製成的鼻香膏。 Path-Away®是一種基於植物的不含酒精的活性成分，已被證明可以殺死所有先前已知的冠狀病毒，且不會對人造成傷害。 Path-Away®由Global Infection Control Consultants LLC（以下簡稱“ GICC LCC”）研發，該成分已被證明可殺死170多種病原體（包括病毒，細菌和真菌）。它可以殺死艾滋病毒以及極其頑固的結核分枝桿菌。馬來西亞衛生部批准其對H1N1病毒有效。 GICC LLC由其總裁兼首席研究科學家Arthur Martin博士創立，位於南卡羅來納州布盧夫頓。 共同為全球市場研發鼻香消毒膏 Martin博士和Holista創始人兼首席執行官Rajen Manicka博士共同宣布：“Covid-19疫情爆發後，兩家公司將擴大合作夥伴關係，並加快包含Path-Away®鼻香消毒膏的研發。” 兩家公司預計將於2020年第一季度共同申請鼻香消毒膏的全球專利，併計劃於2020年第三季度開始生產，然後在英國和歐洲的冬季開始前將其分銷至全球分銷。 鼻香膏將含有Path-Away®成分，它是由GICC LLC專有的一系列獨立工廠和工藝製成的。 Path-Away®會附著在病毒上，並通過抑制其吸收氨基酸（細胞的基本組成部分）的能力來削弱細胞壁。這迫使病毒細胞凝結在一起，並在此過程中幾乎立刻殺死自己。 Martin博士說：“空氣傳播的病毒只能通過眼睛，嘴巴和鼻子進入人體。口腔受唾液酶保護，眼睛會產生淚液，其中含有可以破壞病毒表面蛋白質的特定酶。但是，鼻子溫暖，潮濕且黑暗，尤其是在冬天。鼻腔通道富含脂肪和氨基酸，直接通向鼻竇，喉嚨，當然還有肺，因此最易受到病毒的侵害。” “我們很高興與Holista合作研發出相當於NatShield™消毒液的鼻香消毒膏，因為口罩過於鬆散，無法完全貼合面部，不能為鼻子提供全方位保護。這可能會使小液滴進入口腔或鼻子。由於Path-Away®是基於植物的且不含酒精，因此對鼻子無刺激性，有效期為六個小時。”他補充道。 手持消毒液最新進展；與菲律賓裝瓶商合作 由Holista研發的含有Path-Away®的手持式NatShield™消毒液目前在馬來西亞裝瓶，並在東盟的10個國家/地區銷售。當地藥房的存貨已用盡，Holista表示其已與菲律賓的3家裝瓶商合作來滿足訂單需求。 Holista CollTech首席執行官Rajen Manicka博士說：“鑑於對Covid-19的擔憂，Holista努力滿足馬來西亞和澳大利亞本地對消毒液的需求。” 分銷拓展至東盟外（包括英國和歐洲） GICC LLC已同意向Holista授予Path-Away®在東盟以外（包括英國和歐洲）的營銷和分銷權。 Holista將向英國和歐洲分銷NatShield™消毒液和鼻香消毒膏。 Holista還將與GICC LLC在北美市場合作，銷售NatShield™消毒液和鼻香消毒膏。 “我們也感謝Martin博士和GICC LCC授予Holista針對Path-Away®的歐洲分銷權。我們很高興與Martin博士的團隊針對Natshield™消毒液在北美市場進行合作。”他補充說。 淨化建築物和設施中氣流的設備 在資深工程師Martin博士的領導下，GICC LCC還開發了一套設備和過程，可幫助在機場，交通樞紐，醫院，學校和工廠等建築物中部署Path-Away®，以改善空氣質量。解決方案包括將含有Path-Away®的薄霧泵入空調和通風系統，以消滅此類封閉公共場所中存在的致命病原體。 PathAway®已在多個國家和市場領域使用了十多年，用以預防疾病和提高生產效率。 GICC LLC曾於2009年使用PathAway®在H1N1流感爆發期間為馬來西亞提供幫助，並在2003年的SARS爆發期間為新加坡提供了幫助。 Holista現將在中國大陸，澳門，香港和台灣地區以外的亞太地區獨家代理該技術。 資金更新 正如本月早些時候公司向澳大利亞證券交易提交的公告，自2020年初以來，該公司已利用資本控製配售協議（Acuity Capital Control Placement Agreement, 簡稱CPA）成功籌集了超過$ 2,600,000的資金。這筆資金將用於開發鼻香消毒膏，發展現有的區域市場以及新的歐洲市場，且不會中斷業務運營。 Holista CollTech Ltd簡介 Holista CollTech Ltd（以下簡稱“Holista”）是一家以科研為重心的生物技術公司，由Holista Biotech SdnBhd與CollTech Australia Ltd.合併而成。集團總部位於珀斯，在馬來西亞擁有廣泛業務。該公司致力於為全球市場提供一流的天然成分和健康產品。 Holista是草藥和成分研究的領導者，旨在為消費者提供更健康的食品。 Holista在澳大利亞證券交易所（“ ASX”）上市，致力於研究、開發，製造和銷售“健康型”產品，以滿足針對天然藥物的未被滿足且不斷變化的需求。 Holista的配料組合包括低GI烘焙產品，低鈉鹽，低脂油炸食品和低熱量糖，同時又不影響口味，氣味和口感。 Holista仍是唯一一家使用專利提取方法生產綿羊膠原蛋白的公司。更多資訊，請訪問http://www.holistaco.com 進一步諮詢，請聯繫： 企業事務與商機 Rajen Manicka博士： rajen.m@holistaco.com 常規諮詢：enquiries@holistaco.com 媒體與投資者關係諮詢 WeR1 Consultants Pte Ltd E: holista@wer1.net; P: +65 67374844
Holista将含Path-Away(R)成分的消毒液的分销范围扩展至东盟，英国和欧洲 Holista CollTech（ASX代码：HCT）（以下简称“Holista”或本公司）今日宣布，它将在马来西亚与合作伙伴一起共同研发和生产世界上第一款使用Path-Away®制成的鼻香膏。Path-Away®是一种基于植物的不含酒精的活性成分，已被证明可以杀死所有先前已知的冠状病毒，且不会对人造成伤害。 Path-Away®由Global Infection Control Consultants LLC（以下简称“ GICC LCC”）研发，该成分已被证明可杀死170多种病原体（包括病毒，细菌和真菌）。它可以杀死艾滋病毒以及极其顽固的结核分枝杆菌。马来西亚卫生部批准其对H1N1病毒有效。GICC LLC由其总裁兼首席研究科学家Arthur Martin博士创立，位于南卡罗来纳州布卢夫顿。 共同为全球市场研发鼻香消毒膏 Martin博士和Holista创始人兼首席执行官Rajen Manicka博士共同宣布：“Covid-19疫情爆发后，两家公司将扩大合作伙伴关系，并加快包含Path-Away®鼻香消毒膏的研发。” 两家公司预计将于2020年第一季度共同申请鼻香消毒膏的全球专利，并计划于2020年第三季度开始生产，然后在英国和欧洲的冬季开始前将其分销至全球分销。 鼻香膏将含有Path-Away®成分，它是由GICC LLC专有的一系列独立工厂和工艺制成的。Path-Away®会附着在病毒上，并通过抑制其吸收氨基酸（细胞的基本组成部分）的能力来削弱细胞壁。这迫使病毒细胞凝结在一起，并在此过程中几乎立刻杀死自己。 Martin博士说：“空气传播的病毒只能通过眼睛，嘴巴和鼻子进入人体。口腔受唾液酶保护，眼睛会产生泪液，其中含有可以破坏病毒表面蛋白质的特定酶。但是，鼻子温暖，潮湿且黑暗，尤其是在冬天。鼻腔通道富含脂肪和氨基酸，直接通向鼻窦，喉咙，当然还有肺，因此最易受到病毒的侵害。” “我们很高兴与Holista合作研发出相当于NatShield™消毒液的鼻香消毒膏，因为口罩过于松散，无法完全贴合面部，不能为鼻子提供全方位保护。这可能会使小液滴进入口腔或鼻子。由于Path-Away®是基于植物的且不含酒精，因此对鼻子无刺激性，有效期为六个小时。”他补充道。 手持消毒液最新进展；与菲律宾装瓶商合作 由Holista研发的含有Path-Away®的手持式NatShield™消毒液目前在马来西亚装瓶，并在东盟的10个国家/地区销售。当地药房的存货已用尽，Holista表示其已与菲律宾的3家装瓶商合作来满足订单需求。 Holista CollTech首席执行官Rajen Manicka博士说：“鉴于对Covid-19的担忧，Holista努力满足马来西亚和澳大利亚本地对消毒液的需求。” 分销拓展至东盟外（包括英国和欧洲） GICC LLC已同意向Holista授予Path-Away®在东盟以外（包括英国和欧洲）的营销和分销权。Holista将向英国和欧洲分销NatShield™消毒液和鼻香消毒膏。Holista还将与GICC LLC在北美市场合作，销售NatShield™消毒液和鼻香消毒膏。 “我们也感谢Martin博士和GICC LCC授予Holista针对Path-Away®的欧洲分销权。我们很高兴与Martin博士的团队针对Natshield™消毒液在北美市场进行合作。”他补充说。 净化建筑物和设施中气流的设备 在资深工程师Martin博士的领导下，GICC LCC还开发了一套设备和过程，可帮助在机场，交通枢纽，医院，学校和工厂等建筑物中部署Path-Away®，以改善空气质量。解决方案包括将含有Path-Away®的薄雾泵入空调和通风系统，以消灭此类封闭公共场所中存在的致命病原体。 PathAway®已在多个国家和市场领域使用了十多年，用以预防疾病和提高生产效率。 GICC LLC曾于2009年使用PathAway®在H1N1流感爆发期间为马来西亚提供帮助，并在2003年的SARS爆发期间为新加坡提供了帮助。 Holista现将在中国大陆，澳门，香港和台湾地区以外的亚太地区独家代理该技术。 资金更新 正如本月早些时候公司向澳大利亚证券交易提交的公告，自2020年初以来，该公司已利用资本控制配售协议（Acuity Capital Control Placement Agreement, 简称CPA）成功筹集了超过$ 2,600,000的资金。这笔资金将用于开发鼻香消毒膏，发展现有的区域市场以及新的欧洲市场，且不会中断业务运营。 Holista CollTech Ltd简介 Holista CollTech Ltd（以下简称“Holista”）是一家以科研为重心的生物技术公司，由Holista Biotech SdnBhd与CollTech Australia Ltd.合并而成。集团总部位于珀斯，在马来西亚拥有广泛业务。该公司致力于为全球市场提供一流的天然成分和健康产品。Holista是草药和成分研究的领导者，旨在为消费者提供更健康的食品。 Holista在澳大利亚证券交易所（“ ASX”）上市，致力于研究、开发，制造和销售“健康型”产品，以满足针对天然药物的未被满足且不断变化的需求。Holista的配料组合包括低GI烘焙产品，低钠盐，低脂油炸食品和低热量糖，同时又不影响口味，气味和口感。Holista仍是唯一一家使用专利提取方法生产绵羊胶原蛋白的公司。更多资讯，请访问http://www.holistaco.com 进一步咨询，请联系： 企业事务与商机 Rajen Manicka博士： rajen.m@holistaco.com 常规咨询：enquiries@holistaco.com 媒体与投资者关系咨询 WeR1 Consultants Pte Ltd E: holista@wer1.net; P: +65 67374844
SINGAPORE, Feb 19, 2020 – (ACN Newswire) – Cloud & Cyber Security Expo, a leading cybersecurity event in the Asia Pacific market, today announced the event’s rebranding in conjunction with its 5th edition happening this 14-15 October at Marina Bay Sands. This initiative solidifies their position in the cybersecurity event industry by encompassing the larger scope of what cybersecurity entails in the digital transformation journey. Event Manager, Dominic Pinfold commented, “Cyber Security World is a response to our delegates’ feedback in 2019, as their interests and needs go beyond just cloud security. With organisations of all sizes digitally transforming in 2020, the threat that…
Infinito Wallet has officially partnered with Simplex to allow users to purchase crypto using credit and debit cards right inside the wallet. When first joining the crypto world, most users make their first purchase on centralized exchanges, where security and privacy are far from guaranteed. For safety reasons, traders are told to keep part of their assets on the exchanges, ready for trading, and the other half on a mobile or hardware wallet. This inconvenience is why Infinito has worked with the leading fiat gateway platform Simplex to give users a single place to buy then protect their crypto assets,…
Yowie Group, the confectionary company bringing families sweet treats combined with an educational experience, today announced the donation of $20,000 to WIRES Wildlife Rescue as a result of their charity donation competition. Over the holiday season, Yowie gave their fans the opportunity to vote for an eco-conservation organization of their choice. The majority of fans directed their votes to WIRES, an Australian wildlife rescue organization, in the wake of the bushfire crisis. WIRES Wildlife Rescue is the largest wildlife rescue and rehabilitation charity in Australia. It is a non-profit organization providing rescue and rehabilitation for all native Australian fauna. All…
DNX Biopharmaceuticals, a biopharmaceutical company developing long-acting therapeutic proteins for the treatment of patients with life-long diseases and a resident of Johnson & Johnson Innovation – JLABS @ Shanghai, announced today that it has entered into a strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson*. Under terms of the agreement, the Lung Cancer Initiative has taken an exclusive license to research, develop and commercialize novel molecules from within the DNX portfolio. Financial terms of the collaboration were not disclosed. “We are delighted to be collaborating with the Lung Cancer Initiative at Johnson & Johnson,” said Rajiv Datar,…
Trintech, a leading global provider of integrated Record to Report software solutions for the office of finance, today announced successful certifications by the SAP Integration and Certification Center (SAP ICC). Trintech’s Cadency® 8.0 and Cadency RPA and Journal Management (ERP Bots) have been SAP-certified for integration with both SAP S/4HANA® and powered by SAP NetWeaver®. The latest certifications for Trintech also support deployment and compatibility with all earlier versions of SAP® software. The latest certifications include: – Trintech Cadency V8.0 for SAP ERP (Connectors to extract data out of SAP ERP and import into Cadency) – Trintech Cadency V8.0 for…
CITIC Telecom International CPC Limited (CITIC Telecom CPC), a wholly-owned subsidiary of CITIC Telecom International Holdings Limited (SEHK: 1883) today announced its launch of remote working solutions (cloud desktop – Desktop-as-a-Service, DaaS; remote access – IPSec VPN and SSL VPN) which is fast to deploy and can allow enterprises to ensure business continuity. With the remote working solutions, staff can securely and stably connect to their enterprises critical systems through their smart devices. The solutions support cross-regional use including Mainland China, Hong Kong, Macau, Taiwan, Southeast Asia, and Europe. Enterprises’ staff can be assured of maintaining strong collaboration while working…
Distributable income reached HK$1,648 million, up 2.3%; The portfolio continued to see positive rental reversion Champion Real Estate Investment Trust (stock code: 2778), the owner of Three Garden Road and Langham Place, announces its financial results for year ended 31 December 2019. Summary of financial results FY 2019 FY 2018 Change Total Rental Income (HK$ mil) 2,778 2,677 + 3.8% Net Property Income (HK$ mil) 2,481 2,405 + 3.1% Distributable Income (HK$ mil) 1,648 1,611 + 2.3% Distribution per unit (HK$) 0.2666 0.2614 + 2.0% Value as at 31 Dec 2019 31 Dec 2018 Change Gross Value of Portfolio (HK$…
AIM ImmunoTech (NYSE American: AIM), an immuno-pharma company focused on the research and development of therapeutics to treat immune disorders, viral diseases and multiple types of cancers, today provided its stockholders with an update on its efforts to develop Ampligen as a protective therapeutic and a vaccine in the new coronavirus epidemic. Ampligen, the company’s flagship drug, has a commercial approval in Argentina, early-access therapeutic approval in the Netherlands, and is in numerous FDA-authorized clinical trials in the United States. This letter provides a detailed scientific basis for why the company is moving forward in the important and volatile Wuhan…
MetaQuotes’ Press Office has announced the MetaTrader 5 platform (https://www.metatrader5.com/en) launch by the listed German Fintech firm NAGA. The German brand enhanced its overall trading experience and successfully expanded its multi-asset offering to provide its growing network of clients with direct market access to stocks listed on 9 global exchanges, including NASDAQ, NYSE, London Stock Exchange, HKE, Borse Frankfurt and BME, among others. NAGA has built its offering to provide the greatest possible advantages to clients looking to invest in real shares, enabling them to buy and sell shares of the biggest publicly listed companies worldwide. “Our mission at NAGA…
Commences operating leasing business in the Philippines; Further extends the Group’s footprints in Asia strategically Asia Pioneer Entertainment Holdings Limited (“APE Holdings” or the “Company”, with its subsidiaries collectively referred as the “Group”; Stock Code: 8400.HK) is pleased to announce that its wholly-owned subsidiary, Asia Pioneer Entertainment Limited (“APE”) entered into an Operating Lease Agreement (“Agreement”) with Glimex Inc. (“Glimex”) on 31 January 2020, to lease electronic gaming equipment (“EGEs” or “Leased Equipment”) to Glimex, for use at Palace Casino located at JPark Island Resort in Cebu the Philippines, for a term of 24 months. Pursuant to the Agreement, APE…
Haejeon Industrial Co Ltd has secured a $18.3M contract with industry partner Samsung C & T Corp in a joint venture to lead development efforts on a large dam construction project in Mali, West Africa. The agreement follows Haejeon’s innovative, leading-edge technologies in the water resources development and irrigation fields, as well as its familiarity with water scarcity concerns in the African region. Haejeon will spearhead installation of the dam, intended to manage river flow and resolve an ongoing regional drought crisis. The company brings years of manufacturing and construction experience to this vital infrastructure…
While the world attention is on the fight against Coronavirus in China, Blue Orca is concerned about other things at the same time. This time, this foreign short selling agency aimed at a high-quality Chinese pharmaceutical company. According to Zhitongcaijing APP, recently, Blue Orca targeted China Medical System (867.HK), a well-known Chinese pharmaceutical company, by releasing a short selling report against the company on the morning of February 6, pointing out that this Chinese pharmaceutical company “is simply uninvestable”. Influenced by this report, the share price of China Medical System fell sharply by 12.7% from its peak at HK$ 10.72…
The short-selling company Blue Orca Capital would not have expected that its confrontation with China Medical System Holdings Limited (“China Medical System”) actually helped the company. The confrontation allowed investors and the whole pharmaceutical industry in China to see the biggest CSO has quietly reached the end of its transformation into a new empire that has established full control over an industrial chain, from sales and marketing to production and quality, and has jumped from the domestic market to a company driven by global R&D innovative resources. By reviewing the seemingly detailed report from Blue Orca Capital (“Orca”) and a…